Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine
1 clinical trials · Condition
◉ Watch Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults (NCT01258062) | Alachua Government Services, Inc. | 2010-09-01 |
Track Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine automatically
Every clearance here is in the API, with alerts when new ones post.